2nd International Conference on Cancer Pharmacology Research
Welcome Message
Dear Friends,
Following the resounding educational and networking success that was the 1st International Conference on Cancer Pharmacology Research, December 13-16, 2017 in New York City, USA, it is a distinct privilege to welcome back our faculty, presenters, and participants from that meeting, as well as many new presenters and participants.
This time I would like to invite participants across the world to attend the 2nd International Conference on Cancer Pharmacology Research, scheduled to be held on August 29- September 1, 2019 in Weifang Medical University, Weifang, Shandong, China.
The conference will feature keynote, plenary, scientific sessions and also Meet The Expert (MTE) sessions led by invited experts in their respective disciplines. We will also be selecting speakers based on submitted abstracts.
In addition, there will be a poster session, and all posters will be available for viewing throughout the conference. Ample time will be setaside for presenters to be at their posters to foster discussion. The oral and poster sessions will be classified as basic, translational, and clinical to help registrants plan their program. The topics of this meeting are related to new progress in molecular targets and cancer immune-therapy, cancer precision medicine and anticancer drug resistance in cancer, etc. The fields to be addressed also include:
| ABC Transporters and Cancer Chemotherapy | Anti-cancer Drug Discovery and Delivery |
| Carcinogenesis | Chemoprevention |
| Clinical Cancer Research | Epidemiology and Prevention of Cancer |
| Genetics, Genomics, and Proteomics and Cancer | Inflammation and Cancer |
| Metabolism and Cancer | Cancer Stem Cells |
| Microbiology and Cancer | Radiology and Cancer |
The goal is to highlight the recent advances in understanding, treating and eradicating cancer. We plan to invite Graduate Students, Pharmacologists, Cancer Researchers, Oncologists, Cancer Associations and Societies, Business Entrepreneurs, Training Institutes, and Manufacturing Medical Devices Companies.
We look forward to your participation in this meeting.
Prof. Zhe-Sheng (Jason) Chen, MD., Ph. D.
Director, Institute for Biotechnology
Professor of Cancer Pharmacology
College of Pharmacy and Health Sciences
St. John’s University
8000 Utopia Parkway
Queens, NY 11439, USA
Tel: +1-718-990-1432 (USA), 86-13060846952 (China)
Email: chenz@stjohns.edu (USA), chenzhs@wfmc.edu.cn (China)
